Skip to main content
HealthConfirmedMediumDeveloping
5.3

PAHO and The Lancet advocate for COVID-19 vaccine reformulation to reduce reactogenicity

The Pan American Health Organization and The Lancet are pushing for a shift in COVID-19 vaccine strategy to address public hesitancy regarding adverse effects. The initiative focuses on developing formulations with lower reactogenicity to improve long-term immunization uptake.

Clarínabout 8 hours agoUSCredibility 30%View source

Score Breakdown

Mosaic Score5.3
Confidence0.9
Significance0.5
Source credibility0.3
Source

Related signals

8 found